NAF1 and breast cancer: Suppression of NAF-1 expression in human breast cancer cells appears, therefore, to reduce their tumorigenicity by interfering with cellular Fe ion distribution and energy metabolism, resulting in the enhanced accumulation of Fe ions and ROS in the mitochondria, and the activation of apoptosis.